INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) shares dropped 0.2% on Thursday . The stock traded as low as $0.45 and last traded at $0.46. Approximately 21,488 shares changed hands during trading, a decline of 99% from the average daily volume of 1,587,563 shares. The stock had previously closed at $0.46.
INVO Bioscience Stock Down 5.4 %
The stock’s 50 day moving average is $0.70 and its two-hundred day moving average is $0.78.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in INVO Bioscience stock. CWC Advisors LLC. bought a new position in shares of INVO Bioscience, Inc. (NASDAQ:INVO – Free Report) in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 100,477 shares of the company’s stock, valued at approximately $71,000. CWC Advisors LLC. owned approximately 2.64% of INVO Bioscience as of its most recent SEC filing. Institutional investors own 12.02% of the company’s stock.
About INVO Bioscience
INVO Bioscience, Inc, together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.
Recommended Stories
- Five stocks we like better than INVO Bioscience
- Stock Market Upgrades: What Are They?
- Chipotle’s Slip: A Short-Term Dip or Long-Term Opportunity?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Why New Tariffs Could Boost These 3 Basic Materials Stocks
- What Are the U.K. Market Holidays? How to Invest and Trade
- MarketBeat Week in Review – 02/03 – 02/07
Receive News & Ratings for INVO Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INVO Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.